-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2019 to Q2 2025.
- Y-mAbs Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $7K, a 93% decline year-over-year.
- Y-mAbs Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2025 was -$394K, a 161% decline year-over-year.
- Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was -$146K, a 126% decline from 2023.
- Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $561K.
- Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)